Minimising permanent pacemaker implantation (PPI) after TAVI

Philip MacCarthy; Azfar Zaman; Neal Uren; James Cockburn; Stephen Dorman; Iqbal Malik; Douglas Muir; Muhiddin Mick Ozkor; David Smith; Sarah Shield

doi:10.5837/bjc.2021.020

Minimising permanent pacemaker implantation (PPI) after TAVI

Br J Cardiol. 2021 Apr 22;28(2):20. doi: 10.5837/bjc.2021.020. eCollection 2021.

Authors

Philip MacCarthy¹, Azfar Zaman², Neal Uren³, James Cockburn⁴, Stephen Dorman⁵, Iqbal Malik⁶, Douglas Muir⁷, Muhiddin Mick Ozkor⁸, David Smith⁹, Sarah Shield¹⁰

Affiliations

¹ Professor in Cardiology King's College Hospital NHS Foundation Trust, Denmark Hill, Brixton, London, SE5 9RS.
² Professor of Cardiology Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Freeman Road, High Heaton, Newcastle-upon-Tyne, NE7 7DN.
³ Professor in Cardiology NHS Lothian, Waverley Gate, 2-4 Waterloo Place, Edinburgh, EH1 3EG.
⁴ Consultant Cardiologist Brighton and Sussex University Hospitals NHS Trust, Kemptown, Brighton, BN2 1ES.
⁵ Consultant Cardiologist University Hospitals Bristol NHS Foundation Trust, Trust Headquarters, Marlborough Street, Bristol, BS1 3NU.
⁶ Consultant Cardiologist Imperial College Healthcare NHS Trust, The Bays, S Wharf Road, Paddington, London, W2 1NY.
⁷ Consultant Cardiologist South Tees Hospital NHS Foundation Trust, Marton Road, Middlesborough, TS4 3BW.
⁸ Consultant Cardiologist Barts Health NHS Trust, The Royal Hospital, Whitechapel Road, London, E1 1BB.
⁹ Consultant Cardiologist Swansea Bay University Health Board, 1 Talbot Gateway, Baglan Energy Park, Baglan, Port Talbot, SA12 7BR.
¹⁰ Principal Healthcare Consultant Wilmington Healthcare, 5th Floor, 10 Whitechapel High Street, London, E1 8QS.

Abstract

Increased demand for transcatheter aortic valve implantation (TAVI) procedures for patients with severe aortic stenosis has not been matched with a proportional increase in available resources in recent years. This article highlights the importance of developing integrated care pathways for TAVI, which incorporate standardised protocols for permanent pacemaker implantation (PPI) to ensure best practice, increase service efficiency and reduce rates of PPI post-TAVI.

Keywords: aortic valve stenosis; artificial transcatheter aortic valve replacement; heart valve diseases; pacemaker.

Grants and funding

Funding This project is managed as an independent programme developed by an expert clinical panel, led by Professor Philip MacCarthy, with the support of Wilmington Healthcare Ltd., and fully funded by Edwards Lifesciences plc. All content is independent of, and not influenced by, Edwards Lifesciences plc.